SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001601485-24-000078
Filing Date
2024-11-13
Accepted
2024-11-13 16:21:07
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 eltx-11122024formsx3gkcc.htm S-3 235573
2 EX-FILING FEES elicio-ex107calculationo.htm EX-FILING FEES 2437
3 EX-5.1 elicio-51opinionnovember.htm EX-5.1 5660
4 EX-23.1 eliciotherapeuticsinc111.htm EX-23.1 1367
5 elicio-51opinionnovember001.jpg GRAPHIC 228743
6 elicio-51opinionnovember002.jpg GRAPHIC 88374
7 elicio-ex107calculationo001.jpg GRAPHIC 102829
8 eliciotherapeuticsinc111001.jpg GRAPHIC 64861
9 image_0.jpg GRAPHIC 5380
10 image_1.jpg GRAPHIC 5383
  Complete submission text file 0001601485-24-000078.txt   929267
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283199 | Film No.: 241454622
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)